Comprehensive molecular portraits of human breast tumours Brigham & Women’s Hospital & Harvard Medical School Chin Lynda 9 11 Park ... Nature 490 (7418), 61-70, 2012 | 11062 | 2012 |
Comprehensive molecular characterization of human colon and rectal cancer Cancer Genome Atlas Network Nature 487 (7407), 330, 2012 | 7415 | 2012 |
Integrated genomic analyses of ovarian carcinoma Cancer Genome Atlas Research Network Nature 474 (7353), 609, 2011 | 6831 | 2011 |
Inferring tumour purity and stromal and immune cell admixture from expression data K Yoshihara, M Shahmoradgoli, E Martínez, R Vegesna, H Kim, ... Nature communications 4 (1), 2612, 2013 | 6251 | 2013 |
Comprehensive molecular characterization of gastric adenocarcinoma Cancer Genome Atlas Research Network Nature 513 (7517), 202, 2014 | 5127 | 2014 |
Integrated genomic characterization of endometrial carcinoma DA Levine, ... Nature 497 (7447), 67-73, 2013 | 4822 | 2013 |
Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia Cancer Genome Atlas Research Network New England Journal of Medicine 368 (22), 2059-2074, 2013 | 4632 | 2013 |
The immune landscape of cancer V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ... Immunity 48 (4), 812-830. e14, 2018 | 4400 | 2018 |
Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas Cancer Genome Atlas Research Network New England Journal of Medicine 372 (26), 2481-2498, 2015 | 2899 | 2015 |
Comprehensive molecular characterization of clear cell renal cell carcinoma Cancer Genome Atlas Research Network Analysis working group: Baylor College ... Nature 499 (7456), 43-49, 2013 | 2808 | 2013 |
Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma H Noushmehr, DJ Weisenberger, K Diefes, HS Phillips, K Pujara, ... Cancer cell 17 (5), 510-522, 2010 | 2713 | 2010 |
Comprehensive molecular characterization of urothelial bladder carcinoma Cancer Genome Atlas Research Network Nature 507 (7492), 315, 2014 | 2603 | 2014 |
The molecular taxonomy of primary prostate cancer A Abeshouse, J Ahn, R Akbani, A Ally, S Amin, CD Andry, M Annala, ... Cell 163 (4), 1011-1025, 2015 | 2598 | 2015 |
An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics J Liu, T Lichtenberg, KA Hoadley, LM Poisson, AJ Lazar, AD Cherniack, ... Cell 173 (2), 400-416. e11, 2018 | 2578 | 2018 |
Oncogenic signaling pathways in the cancer genome atlas F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ... Cell 173 (2), 321-337. e10, 2018 | 2441 | 2018 |
Comprehensive characterization of cancer driver genes and mutations MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ... Cell 173 (2), 371-385. e18, 2018 | 2155 | 2018 |
Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer KA Hoadley, C Yau, T Hinoue, DM Wolf, AJ Lazar, E Drill, R Shen, ... Cell 173 (2), 291-304. e6, 2018 | 2019 | 2018 |
Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma M Ceccarelli, FP Barthel, TM Malta, TS Sabedot, SR Salama, BA Murray, ... Cell 164 (3), 550-563, 2016 | 1992 | 2016 |
Absolute quantification of somatic DNA alterations in human cancer SL Carter, K Cibulskis, E Helman, A McKenna, H Shen, T Zack, PW Laird, ... Nature biotechnology 30 (5), 413-421, 2012 | 1987 | 2012 |
Comprehensive analyses of tumor immunity: implications for cancer immunotherapy B Li, E Severson, JC Pignon, H Zhao, T Li, J Novak, P Jiang, H Shen, ... Genome biology 17, 1-16, 2016 | 1912 | 2016 |